News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,787 Results
Type
Article (43308)
Company Profile (284)
Press Release (692178)
Multimedia
Podcasts (100)
Webinars (20)
Section
Business (206516)
Career Advice (2042)
Deals (35769)
Drug Delivery (134)
Drug Development (82195)
Employer Resources (174)
FDA (16689)
Job Trends (15076)
News (349744)
Policy (33269)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2646)
Accelerated approval (46)
Adcomms (26)
Allergies (168)
Alliances (50388)
ALS (199)
Alzheimer's disease (1777)
Antibody-drug conjugate (ADC) (433)
Approvals (17010)
Artificial intelligence (642)
Autoimmune disease (249)
Automation (54)
Bankruptcy (364)
Best Places to Work (11701)
BIOSECURE Act (22)
Biosimilars (223)
Biotechnology (189)
Bladder cancer (183)
Brain cancer (69)
Breast cancer (719)
Cancer (5639)
Cardiovascular disease (456)
Career advice (1732)
Career pathing (41)
CAR-T (314)
CDC (56)
Celiac Disease (2)
Cell therapy (841)
Cervical cancer (44)
Clinical research (70973)
Collaboration (2026)
Company closure (6)
Compensation (1333)
Complete response letters (84)
COVID-19 (2782)
CRISPR (102)
C-suite (1057)
Cystic fibrosis (151)
Data (7458)
Decentralized trials (3)
Denatured (32)
Depression (158)
Dermatology (70)
Diabetes (565)
Diagnostics (6927)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (316)
Drug pricing (201)
Drug shortages (32)
Duchenne muscular dystrophy (274)
Earnings (91494)
Editorial (68)
Employer branding (21)
Employer resources (153)
Events (119870)
Executive appointments (1069)
FDA (20277)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1679)
Gene editing (221)
Generative AI (57)
Gene therapy (692)
GLP-1 (1044)
Government (4837)
Grass and pollen (6)
Guidances (402)
Healthcare (19066)
HIV (76)
Huntington's disease (56)
IgA nephropathy (93)
Immunology and inflammation (289)
Immuno-oncology (91)
Indications (168)
Infectious disease (3119)
Inflammatory bowel disease (210)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (280)
Interviews (318)
IPO (16732)
IRA (51)
Job creations (3690)
Job search strategy (1441)
JPM (59)
Kidney cancer (18)
Labor market (96)
Layoffs (569)
Leadership (38)
Legal (8019)
Liver cancer (99)
Longevity (31)
Lung cancer (754)
Lymphoma (416)
Machine learning (57)
Management (59)
Manufacturing (1009)
MASH (180)
Medical device (13970)
Medtech (14056)
Mergers & acquisitions (20237)
Metabolic disorders (1452)
mRNA (197)
Multiple sclerosis (182)
NASH (17)
Neurodegenerative disease (398)
Neuropsychiatric disorders (102)
Neuroscience (3243)
Neurotech (1)
NextGen: Class of 2026 (6586)
Non-profit (4556)
Now hiring (75)
Obesity (681)
Opinion (291)
Ovarian cancer (207)
Pain (242)
Pancreatic cancer (282)
Parkinson's disease (352)
Partnered (34)
Patents (569)
Patient recruitment (630)
Peanut (64)
People (59906)
Pharmaceutical (62)
Pharmacy benefit managers (32)
Phase 1 (22157)
Phase 2 (31227)
Phase 3 (23265)
Pipeline (7720)
Policy (327)
Postmarket research (2588)
Preclinical (9460)
Press Release (71)
Prostate cancer (284)
Psychedelics (54)
Radiopharmaceuticals (319)
Rare diseases (1046)
Real estate (6055)
Recruiting (70)
Regulatory (25594)
Reports (56)
Research institute (2463)
Resumes & cover letters (354)
Rett syndrome (35)
RNA editing (21)
RSV (90)
Schizophrenia (173)
Series A (277)
Series B (209)
Service/supplier (11)
Sickle cell disease (110)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (47)
Startups (3699)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (89)
The Weekly (66)
Vaccines (1109)
Venture capital (101)
Weight loss (437)
Women's health (118)
Worklife (20)
Date
Last 7 days (761)
Last 30 days (2566)
Last 365 days (30520)
2026 (9963)
2025 (30512)
2024 (35533)
2023 (40388)
2022 (51554)
2021 (56094)
2020 (54453)
2019 (46912)
2018 (35347)
2017 (32545)
2016 (31923)
2015 (37960)
2014 (31753)
2013 (26759)
2012 (28939)
2011 (29648)
2010 (27628)
Location
Africa (754)
Alabama (91)
Alaska (7)
Arizona (339)
Arkansas (15)
Asia (40369)
Australia (6600)
California (12740)
Canada (3637)
China (1299)
Colorado (544)
Connecticut (548)
Delaware (383)
Europe (87552)
Florida (1899)
Georgia (411)
Hawaii (3)
Idaho (62)
Illinois (1005)
India (90)
Indiana (582)
Iowa (24)
Japan (513)
Kansas (130)
Kentucky (48)
Louisiana (39)
Maine (75)
Maryland (1550)
Massachusetts (9123)
Michigan (352)
Minnesota (706)
Mississippi (7)
Missouri (144)
Montana (34)
Nebraska (29)
Nevada (139)
New Hampshire (84)
New Jersey (3371)
New Mexico (28)
New York (3355)
North Carolina (1613)
North Dakota (10)
Northern California (6328)
Ohio (380)
Oklahoma (24)
Oregon (43)
Pennsylvania (2563)
Puerto Rico (28)
Rhode Island (50)
South America (1130)
South Carolina (85)
South Dakota (2)
Southern California (5016)
Tennessee (204)
Texas (2004)
United States (45077)
Utah (383)
Vermont (1)
Virginia (301)
Washington D.C. (81)
Washington State (1018)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
735,787 Results for "synthetic biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™
April 7, 2026
·
3 min read
Press Releases
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
April 16, 2026
·
13 min read
Press Releases
Synthetic Design Lab Unveils First Advanced Logic-Gated ADC at AACR 2026, Achieving ≥10X Improvement in Targeted Cancer Cell Killing
April 20, 2026
·
5 min read
IN PARTNERSHIP WITH AGC BIOLOGICS
Your Scale, Your Terms: How Modular Bioreactors Are Redefining Capacity & Manufacturing Strategies
Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy emphasizing “scale-out” manufacturing, to derisk demand uncertainty, speed timelines and conserve cash for emerging drug developers.
April 13, 2026
·
7 min read
·
Jennifer C. Smith-Parker
Press Releases
BioLab Holdings Announces Investment in Advanced Synthetic Antimicrobial -Tissue Regeneration Solutions
January 28, 2026
·
3 min read
Press Releases
NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
April 7, 2026
·
9 min read
Sponsored
Cracking the Code: Solving Microbial Manufacturing’s Biggest Challenges
Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating biologics also means a race against time, where success hinges on conquering three key challenges: designing a robust microbial strain, optimizing fermentation for industrial scale, and ensuring consistent high-yield product yield.
December 1, 2025
·
6 min read
·
AGC Biologics
Press Releases
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development - February 10, 2026
February 11, 2026
·
3 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
AACR 2026 | Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and Synthetic Lethality Approaches
April 23, 2026
·
8 min read
1 of 73,579
Next
